Paul Goddard, Director at ONYX PHARMACEUTICALS INC (ONXX), sold 4,000 shares at $74.35 ($297K) on 2013-03-01, disclosed to the SEC on 2013-03-05.
Scheduled sale ($297k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ONXX | SELL | 2013-05-03 | $465K | — | Filing → |
| ONXX | SELL | 2013-04-11 | $190K | — | Filing → |
| ONXX | SELL | 2013-03-11 | $85K | — | Filing → |